Benzinga - Gainers
- Motorsport Games Inc. (NASDAQ: MSGM) shares jumped 770% to $22.99. The company announced a debt-for-equity exchange with Motorsport Network. Also, Investor Mike Zoi reported purchase of 338,983 shares of Motorsport Games at an average price of $2.95 per share in Form 4 Filing.
- Atlas Technical Consultants, Inc. (NASDAQ: ATCX) gained 120.7% to $12.07 after the company agreed to be acquired by GI Partners for $12.25 per share in cash.
- Hillstream BioPharma, Inc. (NASDAQ: HILS) jumped 108% to $1.40 after the company announced signing an exclusive option agreement with Dana-Farber Cancer Institute to license technology targeting the MUC1-C oncoprotein.
- Mobile Global Esports Inc. (NASDAQ: MGAM) jumped 62% to $1.62. Mobile Global Esports said Nicholas (Nick) Venezia has joined MOGO as Chief Data Officer.
- Context Therapeutics Inc. (NASDAQ: CNTX) gained 59.4% to $1.0893 after the company announced its clinical trial collaborator, Stemline Therapeutics, received approval from the FDA for ORSERDU in ER+, HER2-, ESR1-mutated breast cancer.
- FaZe Holdings Inc. (NASDAQ: FAZE) gained 37% to $0.9886.
- Hyperfine, Inc. (NASDAQ: HYPR) jumped 36% to $1.1850. The company was granted patent for deep learning techniques for generating magnetic resonance images from Spatial Frequency Data.
- ERYTECH Pharma S.A. (NASDAQ: ERYP) gained 29% to $0.93.
- FOXO Technologies Inc. (NYSE: FOXO) rose 28.7% to $1.1985 after dropping around 7% on Monday.
- SOBR Safe, Inc. (NASDAQ: SOBR) gained 27% to $1.41 after the company announced that its first two SOBRcheck installations in the oil and gas industry were successful.
- MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD) jumped 26.2% to $2.75.
- C3.ai, Inc. (NYSE: AI) shares climbed 25.5% to $20.46 after the company announced the launch of C3 Generative AI Product Suite.
- Akanda Corp. (NASDAQ: AKAN) rose 25% to $0.35.
- Pardes Biosciences, Inc. (NASDAQ: PRDS) rose 25% to $2.25.
- Edible Garden AG Incorporated (NASDAQ: EDBL) gained 24.6% to $10.02.
- Duos Technologies Group, Inc. (NASDAQ: DUOT) jumped 23.7% to $4.80.
- VivoPower International PLC (NASDAQ: VVPR) climbed 22.9% to $0.8746.
- Draganfly Inc. (NASDAQ: DPRO) surged 22.7% to $2.05.
- Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) surged 21.7% to $0.6587. Spectrum Pharmaceuticals said it sees preliminary Q4 net sales of $10 million.
- Palisade Bio, Inc. (NASDAQ: PALI) gained 20% to $2.6891.
- Stitch Fix, Inc. (NASDAQ: SFIX) gained 17.1% to $5.27.
- Mercurity Fintech Holding Inc. (NASDAQ: MFH) jumped 15.6% to $1.26.
- ContraFect Corporation (NASDAQ: CFRX) rose 13.7% to $0.0699 after dropping 10% on Monday. ContraFect recently announcesd lopsided interim results from pivotal bacterial infection study.
- Spotify Technology S.A. (NYSE: SPOT) jumped 11% to $110.95 after the company reported Q4 total revenue increased year over year and issued Q1 guidance.
- A. O. Smith Corporation (NYSE: AOS) surged 10.3% to $65.72 after the company reported better-than-expected Q4 EPS and sales results.
- VistaGen Therapeutics, Inc. (NASDAQ: VTGN) gained 10.2% to $0.2523.
- Inter & Co, Inc. (NASDAQ: INTR) gained 10.1% to $2.72 after Goldman Sachs upgraded the stock from Neutral to Buy and lowered its price target from $4.60 to $4.20.
- Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares rose 9.8% to $1.68. Panbela Therapeutics 13G filing showed Lind Global Partners reported a 9.9% passive stake in the company.
- Ucommune International Ltd (NASDAQ: UK) rose 9.4% to $1.5973 after gaining over 4% on Monday.
- International Paper Company (NYSE: IP) gained 9.2% to $41.29 after the company reported better-than-expected Q4 adjusted EPS results.
- Sensata Technologies Holding plc (NYSE: ST) jumped 9.1% to $50.06 after the company reported better-than-expected Q4 adjusted EPS and sales results.
- Sanmina Corp (NASDAQ: SANM) rose 7% to $59.42 after the company posted better-than-expected earnings for its first quarter and issued strong FY23 guidance.
- Sidus Space, Inc. (NASDAQ: SIDU) dipped 56% to $0.3918 after dropping 16% on Monday. Sidus Space recently expanded commercial data distribution strategy through agreement with SkyWatch.
- Nuvve Holding Corp. (NASDAQ: NVVE) shares dipped 41.1% to $1.3550 after the company filed for common stock offering of up to $25 million.
- AppTech Payments Corp. (NASDAQ: APCX) fell 25.6% to $3.97. AppTech Payments reported pricing of $5 million registered direct offering and concurrent private placement.
- MMTec, Inc. (NASDAQ: MTC) fell 25.1% to $0.7199.
- NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS) fell 23.1% to $13.31. NewAmsterdam Pharma recently announced topline results from ROSE2 Phase 2 trial evaluating obicetrapib in combination with ezetimibe as an adjunct to high-intensity statin therapy.
- Brera Holdings PLC (NASDAQ: BREA) dropped 16.6% to $4.82.
- Smart for Life, Inc. (NASDAQ: SMFL) fell 16.3% to $0.1841.
- MicroAlgo Inc. (NASDAQ: MLGO) fell 15.8% to $2.30.
- CN Energy Group. Inc. (NASDAQ: CNEY) dipped 15.7% to $0.4964. CNEY announced pricing of $10 million underwritten public offering.
- Alvarium Tiedemann Holdings, Inc. (NASDAQ: ALTI) fell 14.8% to $7.80.
- Heart Test Laboratories, Inc. (NASDAQ: HSCS) fell 14.9% to $2.00. Heart Test Laboratories shares jumped 168% on Monday after Ascendant Capital initiated coverage on the the stock with a Buy rating and a $3.30 price target.
- Blackboxstocks Inc. (NASDAQ: BLBX) fell 13.8% to $0.62 after jumping over 67% on Monday. Blackboxstocks recently extended its $2.5 million stock buyback program through 2023.
- Scilex Holding Company (NASDAQ: SCLX) dropped 10.3% to $7.79.
- Woodward, Inc. (NASDAQ: WWD) fell 10.1% to $98.24 following weak quarterly earnings.
- Aethlon Medical, Inc. (NASDAQ: AEMD) shares fell 8.4% to $0.62. Aethlon Medical shares jumped 35% on Monday after Aethlon announced an agreement for NAMSA to support its clinical trials of Hemopurifier.
- Harmonic Inc. (NASDAQ: HLIT) fell 6.5% to $13.28. Harmonic posted better-than-expected Q4 results.
- Phillips 66 (NYSE: PSX) dropped 6% to $100.00 after the company reported worse-than-expected Q4 EPS.
- Caterpillar Inc. (NYSE: CAT) fell 4.1% to $250.63 after the company reported worse-than-expected Q4 adjusted EPS results.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.